Total Payments
$242,000
2021 Payments
$12,617
Companies
5
Transactions
223
Payment Breakdown by Category
Other$204,548 (84.5%)
Travel$34,751 (14.4%)
Food & Beverage$2,685 (1.1%)
Education$17.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $186,420 | 57 | 77.0% |
| Travel and Lodging | $34,751 | 102 | 14.4% |
| Honoraria | $18,128 | 19 | 7.5% |
| Food and Beverage | $2,685 | 44 | 1.1% |
| Education | $17.24 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $188,489 | 173 | $0 (2021) |
| Celgene Corporation | $35,258 | 28 | $0 (2018) |
| Blueprint Medicines Corporation | $18,218 | 20 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $18.23 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $17.24 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $12,617 | 11 | Blueprint Medicines Corporation ($9,867) |
| 2020 | $19,108 | 19 | Merck Sharp & Dohme Corporation ($10,740) |
| 2019 | $87,611 | 93 | Merck Sharp & Dohme Corporation ($87,611) |
| 2018 | $78,102 | 63 | Merck Sharp & Dohme Corporation ($62,006) |
| 2017 | $44,563 | 37 | Merck Sharp & Dohme Corporation ($25,382) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/29/2021 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Honoraria | Cash or cash equivalent | $990.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/25/2021 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $2,612.50 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/25/2021 | Blueprint Medicines Corporation | GAVRETO (Drug) | Travel and Lodging | Cash or cash equivalent | $89.60 | General |
| Category: Oncology / Rare Diseases | ||||||
| 07/07/2021 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 06/23/2021 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 06/23/2021 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $475.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 05/26/2021 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 05/26/2021 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 04/21/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2021 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 01/27/2021 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/21/2020 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/16/2020 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/08/2020 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/08/2020 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $275.50 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/02/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2020 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/02/2020 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/04/2020 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/21/2020 | Blueprint Medicines Corporation | GAVRETO (Drug) | Honoraria | Cash or cash equivalent | $950.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/14/2020 | Blueprint Medicines Corporation | — | Honoraria | Cash or cash equivalent | $475.00 | General |
| 08/26/2020 | Blueprint Medicines Corporation | — | Honoraria | Cash or cash equivalent | $950.00 | General |
| 07/30/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $17.24 | General |
| Category: Oncology | ||||||
| 04/22/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: ONCOLOGY | ||||||
| 04/22/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: ONCOLOGY | ||||||
About Klaus Wagner, MD PHD
Klaus Wagner, MD PHD is a Medical Oncology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1841458023.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Klaus Wagner, MD PHD has received a total of $242,000 in payments from pharmaceutical and medical device companies, with $12,617 received in 2021. These payments were reported across 223 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($186,420).
Ad
Practice Information
- Specialty Medical Oncology
- Location San Diego, CA
- Active Since 05/24/2008
- Last Updated 01/07/2016
- Taxonomy Code 207RX0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841458023
Products in Payments
- KEYTRUDA (Biological) $184,138
- Abraxane (Drug) $31,418
- GAVRETO (Drug) $15,803
- AYVAKIT (Drug) $990.00
- OPDIVO (Biological) $17.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in San Diego
Dr. April Teitelbaum, Md, MD
Medical Oncology — Payments: $567,012
Medical Oncology $567,012
Dr. Seung-Yil Song, M.d, M.D
Medical Oncology — Payments: $27,824
Medical Oncology $27,824
Dr. Kathryn Bollin, M.d, M.D
Medical Oncology — Payments: $10,010
Medical Oncology $10,010
Dawood Findakly, Md, MD
Medical Oncology — Payments: $4,580
Medical Oncology $4,580
Dr. Pratik Multani, Md, MD
Medical Oncology — Payments: $1,013
Medical Oncology $1,013
Manorama Reddy, M.d, M.D
Medical Oncology — Payments: $898.68
Medical Oncology $898.68